Candid Health
Billy Deitch is a Partner at Oak HC/FT since January 2018, with extensive investment experience in healthcare and technology companies. Current investment roles include Candid Health, DispatchHealth, Brightline, and Everside Health, all active since 2018 or later. Previous investments include Mendel.ai, Olive, and OODA Health, with notable exits and acquisitions. Deitch served on the Board of Directors for Dynamo Software and QGenda, both of which were acquired. Education includes an MBA from Stanford University Graduate School of Business and a B.A. in History from Yale University.
This person is not in any teams
This person is not in any offices
Candid Health
Candid Health is building a modern medical payments platform that enables healthcare providers to focus on delivering high-quality, affordable and accessible care, rather than spending half their time figuring out how to get paid by insurance.